LYON, FRANCE--(Marketwired - June 30, 2016) - LYONBIOPOLE, the organization dedicated to the strategic international life science cluster in the Auvergne-Rhône-Alpes region, confirms success at BIO 2016, the global event for biotechnology. LYONBIOPOLE was created ten years ago, to support organizations based in the region through economic development, innovation, research facilities and international visibility. With an impressive delegation of 25 companies at BIO 2016, LYONBIOPOLE underlined their commitment to precision medicine, while reinforcing international visibility.
Precision medicine, a founding value for LYONBIOPOLE
Precision medicine was a buzzword at BIO 2016. Creating personalized medicine for the patients' benefit is a key value consistently reinforced at LYONBIOPOLE, since the group inception 10 years ago. This underlying theme and ongoing commitment illustrates LYONBIOPOLE is at the pulse of the life science industry, and a leading international cluster.
A diverse delegation, united under LYONBIOPOLE
Involvement at the BIO international convention is a valuable service LYONBIOPOLE has extended for almost ten years. LYONBIOPOLE offers financial assistance as well as 360-degree support to maximize visibility, potential partners, and international contacts for start-ups and SMEs that otherwise may not attend.
And each year the group has brought more and more companies from the region! At BIO 2016, 25 organizations were united under LYONBIOPOLE, making this the largest delegation at the French pavilion.
"Our first visit to the BIO convention under the umbrella of LYONBIOPOLE has certainly given us visibility! The partnering meetings were an excellent opportunity to entice contacts, prospect business, and explore U.S. market opportunities. And of course we took advantage of the relevant industry conferences at BIO 2016 as well!" shares Emmanuelle Chereul of Voxcan.
Attending the BIO international convention with LYONBIOPOLE is a proven formula for success, explains Thierry Abribat, from Alizé Pharma. "We have been participating in BIO with LYONBIOPOLE for several years, and each time the results exceed our expectations. The LYONBIOPOLE booth attracts influencers from the health sector, the partnering meetings include strategic contacts, and the networking events bring everyone together in one place. Each year, our trip to this event is very worthwhile!"
International visibility, from the U.S. to Europe and Australia!
Further enhancing their commitment to international exposure, the LYONBIOPOLE booth was a meeting point for several delegates at BIO 2016.
- Laurent Wauquiez, President of the Regional Council of Auvergne-Rhône-Alpes, France, met on the LYONBIOPOLE booth for an important exchange with the participating companies, learning more about their needs and discussing the importance of the life science ecosystem.
- John Barros, Chief of Economic Development, City of Boston, met with representatives from the City of Lyon and from LYONBIOPOLE to reinforce ongoing collaboration between the two cities. The discussion is part of an ongoing dialogue to share best practices, based on the common commitment both cities have to innovation, start-ups and life sciences.
- French dignitary Matthias Fekl, Secretary of State for External Trade, met on the LYONBIOPOLE booth and discussed the importance of life sciences in the region and how this brands France internationally.
- At the booth, LYONBIOPOLE, through the alliance BioXclusters+, signed a privileged partnership with Australia. Thanks to cooperation between four major European clusters -- BioPmed (Piedmont), Biocat (Catalonia), BioM (Bavaria) and LYONBIOPOLE -- the partnership will allow South Australian companies aiming for the European market to create new contacts with potential investors.
With organized participation in international events such as the BIO international convention, LYONBIOPOLE will continue to support its members in economic development, innovation, research facilities and international visibility, while maintaining their core value of creating personalized medicine for the patients' benefit.
As a bio cluster, Lyonbiopole is the gateway to healthcare innovation in the Auvergne-Rhône-Alpes region. The cluster supports ambitious projects and companies in the health sector (infectious diseases, cancer, nutrition, metabolic diseases). Their aim is to support innovative technologies, products and services for more personalized medicine that benefits the patient.
Lyonbiopole is involved in 4 strategic areas: human medicine; veterinary medicine; in vitro diagnostics; medical devices. Its missions are: 1) to promote the emergence of innovative R&D collaborative projects; 2) to support SME for strategic partnerships, access to private investors, expertise and training; 3) to foster SME Internationalization and the cluster position at the EU and International levels; 4) to give access to high-level dedicated facilities.
Lyonbiopole received the "Gold Label" by ECEI in 2014. In 2015, Lyonbiopole represented 190 members: 5 world-class leaders including its founders (Sanofi Pasteur, bioMérieux, Merial, BD); 17 Research Centers including 3 Hospital University Centers; 168 SMEs.
More information: www.lyonbiopole.com